APO Research
Talk to an analyst

APO RESEARCH · REPORT

Diagnostic Nuclear Medicines

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Diagnostic Nuclear Medicines Industry Growth and Trends Forecast to 2032

20 December 2025109 pages

Choose your research edition.

Industry ResearchDiagnostic Nuclear Medicines Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Diagnostic Nuclear Medicines Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Diagnostic Nuclear Medicines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Diagnostic Nuclear Medicines Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Diagnostic Nuclear Medicines Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Diagnostic Nuclear Medicines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Diagnostic Nuclear Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Diagnostic Nuclear Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Diagnostic Nuclear Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Diagnostic Nuclear Medicines include Bracco Imaging, Cardinal Health, Curium Pharma, GE Healthcare, Jubilant Pharma, Lantheus, SIEMENS, Dongcheng and Eli Lilly, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Diagnostic Nuclear Medicines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Diagnostic Nuclear Medicines market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Diagnostic Nuclear Medicines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Diagnostic Nuclear Medicines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Diagnostic Nuclear Medicines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Diagnostic Nuclear Medicines Market by Company

Bracco Imaging

Cardinal Health

Curium Pharma

GE Healthcare

Jubilant Pharma

Lantheus

SIEMENS

Dongcheng

Eli Lilly

Novartis

China Isotope & Radiation

Diagnostic Nuclear Medicines Segment by Type

Tc-99m

F-18

Other

Diagnostic Nuclear Medicines Segment by Application

Oncology

Cardiology

Other

Diagnostic Nuclear Medicines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diagnostic Nuclear Medicines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Diagnostic Nuclear Medicines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diagnostic Nuclear Medicines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Diagnostic Nuclear Medicines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Diagnostic Nuclear Medicines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Tc-99m Table 2. Major Company of F-18 Table 3. Major Company of Other Table 4. Global Diagnostic Nuclear Medicines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Diagnostic Nuclear Medicines Sales by Type (2021-2026) & (k units) Table 6. Global Diagnostic Nuclear Medicines Sales Market Share in Volume by Type (2021-2026) Table 7. Global Diagnostic Nuclear Medicines Sales by Type (2021-2026) & (US$ Million) Table 8. Global Diagnostic Nuclear Medicines Sales Market Share in Value by Type (2021-2026) Table 9. Global Diagnostic Nuclear Medicines Price by Type (2021-2026) & (US$/unit) Table 10. Global Diagnostic Nuclear Medicines Sales by Type (2027-2032) & (k units) Table 11. Global Diagnostic Nuclear Medicines Sales Market Share in Volume by Type (2027-2032) Table 12. Global Diagnostic Nuclear Medicines Sales by Type (2027-2032) & (US$ Million) Table 13. Global Diagnostic Nuclear Medicines Sales Market Share in Value by Type (2027-2032) Table 14. Global Diagnostic Nuclear Medicines Price by Type (2027-2032) & (US$/unit) Table 15. North America Diagnostic Nuclear Medicines Sales by Type (2021-2026) & (k units) Table 16. North America Diagnostic Nuclear Medicines Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Diagnostic Nuclear Medicines Sales by Type (2021-2026) & (k units) Table 18. Europe Diagnostic Nuclear Medicines Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Diagnostic Nuclear Medicines Sales by Type (2021-2026) & (k units) Table 20. Asia-Pacific Diagnostic Nuclear Medicines Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Diagnostic Nuclear Medicines Sales by Type (2021-2026) & (k units) Table 22. Latin America Diagnostic Nuclear Medicines Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Diagnostic Nuclear Medicines Sales by Type (2021-2026) & (k units) Table 24. Middle East and Africa Diagnostic Nuclear Medicines Sales by Type (2021-2026) & (US$ Million) Table 25. Diagnostic Nuclear Medicines Industry Trends Table 26. Diagnostic Nuclear Medicines Industry Drivers Table 27. Diagnostic Nuclear Medicines Industry Opportunities and Challenges Table 28. Diagnostic Nuclear Medicines Industry Restraints Table 29. Global Diagnostic Nuclear Medicines Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Diagnostic Nuclear Medicines Revenue Market Share by Company (2021-2026) Table 31. Global Diagnostic Nuclear Medicines Sales by Company (2021-2026) & (k units) Table 32. Global Diagnostic Nuclear Medicines Sales Share by Company (2021-2026) Table 33. Global Diagnostic Nuclear Medicines Market Price by Company (2021-2026) & (US$/unit) Table 34. Global Diagnostic Nuclear Medicines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Diagnostic Nuclear Medicines Major Company Production Sites and Headquarters Table 36. Global Diagnostic Nuclear Medicines Company, Product Type & Application Table 37. Global Diagnostic Nuclear Medicines Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Diagnostic Nuclear Medicines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Diagnostic Nuclear Medicines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Diagnostic Nuclear Medicines Sales by Region (2021-2026) & (k units) Table 42. Global Diagnostic Nuclear Medicines Sales Market Share in Volume by Region (2021-2026) Table 43. Global Diagnostic Nuclear Medicines Sales by Region (2021-2026) & (US$ Million) Table 44. Global Diagnostic Nuclear Medicines Sales Market Share in Value by Region (2021-2026) Table 45. Global Diagnostic Nuclear Medicines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Global Diagnostic Nuclear Medicines Sales by Region (2027-2032) & (k units) Table 47. Global Diagnostic Nuclear Medicines Sales Market Share in Volume by Region (2027-2032) Table 48. Global Diagnostic Nuclear Medicines Sales by Region (2027-2032) & (US$ Million) Table 49. Global Diagnostic Nuclear Medicines Sales Market Share in Value by Region (2027-2032) Table 50. Global Diagnostic Nuclear Medicines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 51. Global Diagnostic Nuclear Medicines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Diagnostic Nuclear Medicines Sales by Application (2021-2026) & (k units) Table 53. Global Diagnostic Nuclear Medicines Sales Market Share in Volume by Application (2021-2026) Table 54. Global Diagnostic Nuclear Medicines Sales by Application (2021-2026) & (US$ Million) Table 55. Global Diagnostic Nuclear Medicines Sales Market Share in Value by Application (2021-2026) Table 56. Global Diagnostic Nuclear Medicines Price by Application (2021-2026) & (US$/unit) Table 57. Global Diagnostic Nuclear Medicines Sales by Application (2027-2032) & (k units) Table 58. Global Diagnostic Nuclear Medicines Sales Market Share in Volume by Application (2027-2032) Table 59. Global Diagnostic Nuclear Medicines Sales by Application (2027-2032) & (US$ Million) Table 60. Global Diagnostic Nuclear Medicines Sales Market Share in Value by Application (2027-2032) Table 61. Global Diagnostic Nuclear Medicines Price by Application (2027-2032) & (US$/unit) Table 62. North America Diagnostic Nuclear Medicines Sales by Application (2021-2026) & (k units) Table 63. North America Diagnostic Nuclear Medicines Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Diagnostic Nuclear Medicines Sales by Application (2021-2026) & (k units) Table 65. Europe Diagnostic Nuclear Medicines Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Diagnostic Nuclear Medicines Sales by Application (2021-2026) & (k units) Table 67. Asia-Pacific Diagnostic Nuclear Medicines Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Diagnostic Nuclear Medicines Sales by Application (2021-2026) & (k units) Table 69. Latin America Diagnostic Nuclear Medicines Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Diagnostic Nuclear Medicines Sales by Application (2021-2026) & (k units) Table 71. Middle East and Africa Diagnostic Nuclear Medicines Sales by Application (2021-2026) & (US$ Million) Table 72. Bracco Imaging Company Information Table 73. Bracco Imaging Business Overview Table 74. Bracco Imaging Diagnostic Nuclear Medicines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Bracco Imaging Diagnostic Nuclear Medicines Product Portfolio Table 76. Bracco Imaging Recent Development Table 77. Cardinal Health Company Information Table 78. Cardinal Health Business Overview Table 79. Cardinal Health Diagnostic Nuclear Medicines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Cardinal Health Diagnostic Nuclear Medicines Product Portfolio Table 81. Cardinal Health Recent Development Table 82. Curium Pharma Company Information Table 83. Curium Pharma Business Overview Table 84. Curium Pharma Diagnostic Nuclear Medicines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Curium Pharma Diagnostic Nuclear Medicines Product Portfolio Table 86. Curium Pharma Recent Development Table 87. GE Healthcare Company Information Table 88. GE Healthcare Business Overview Table 89. GE Healthcare Diagnostic Nuclear Medicines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. GE Healthcare Diagnostic Nuclear Medicines Product Portfolio Table 91. GE Healthcare Recent Development Table 92. Jubilant Pharma Company Information Table 93. Jubilant Pharma Business Overview Table 94. Jubilant Pharma Diagnostic Nuclear Medicines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Jubilant Pharma Diagnostic Nuclear Medicines Product Portfolio Table 96. Jubilant Pharma Recent Development Table 97. Lantheus Company Information Table 98. Lantheus Business Overview Table 99. Lantheus Diagnostic Nuclear Medicines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Lantheus Diagnostic Nuclear Medicines Product Portfolio Table 101. Lantheus Recent Development Table 102. SIEMENS Company Information Table 103. SIEMENS Business Overview Table 104. SIEMENS Diagnostic Nuclear Medicines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. SIEMENS Diagnostic Nuclear Medicines Product Portfolio Table 106. SIEMENS Recent Development Table 107. Dongcheng Company Information Table 108. Dongcheng Business Overview Table 109. Dongcheng Diagnostic Nuclear Medicines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Dongcheng Diagnostic Nuclear Medicines Product Portfolio Table 111. Dongcheng Recent Development Table 112. Eli Lilly Company Information Table 113. Eli Lilly Business Overview Table 114. Eli Lilly Diagnostic Nuclear Medicines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. Eli Lilly Diagnostic Nuclear Medicines Product Portfolio Table 116. Eli Lilly Recent Development Table 117. Novartis Company Information Table 118. Novartis Business Overview Table 119. Novartis Diagnostic Nuclear Medicines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 120. Novartis Diagnostic Nuclear Medicines Product Portfolio Table 121. Novartis Recent Development Table 122. China Isotope & Radiation Company Information Table 123. China Isotope & Radiation Business Overview Table 124. China Isotope & Radiation Diagnostic Nuclear Medicines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 125. China Isotope & Radiation Diagnostic Nuclear Medicines Product Portfolio Table 126. China Isotope & Radiation Recent Development Table 127. North America Diagnostic Nuclear Medicines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 128. North America Diagnostic Nuclear Medicines Sales by Country (2021-2026) & (k units) Table 129. North America Diagnostic Nuclear Medicines Sales Market Share by Country (2021-2026) Table 130. North America Diagnostic Nuclear Medicines Sales Forecast by Country (2027-2032) & (k units) Table 131. North America Diagnostic Nuclear Medicines Sales Market Share Forecast by Country (2027-2032) Table 132. North America Diagnostic Nuclear Medicines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. North America Diagnostic Nuclear Medicines Market Size by Country (2021-2026) & (US$ Million) Table 134. North America Diagnostic Nuclear Medicines Market Share by Country (2021-2026) Table 135. North America Diagnostic Nuclear Medicines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. North America Diagnostic Nuclear Medicines Market Share Forecast by Country (2027-2032) Table 137. Europe Diagnostic Nuclear Medicines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 138. Europe Diagnostic Nuclear Medicines Sales by Country (2021-2026) & (k units) Table 139. Europe Diagnostic Nuclear Medicines Sales Market Share by Country (2021-2026) Table 140. Europe Diagnostic Nuclear Medicines Sales Forecast by Country (2027-2032) & (k units) Table 141. Europe Diagnostic Nuclear Medicines Sales Market Share Forecast by Country (2027-2032) Table 142. Europe Diagnostic Nuclear Medicines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Europe Diagnostic Nuclear Medicines Market Size by Country (2021-2026) & (US$ Million) Table 144. Europe Diagnostic Nuclear Medicines Market Share by Country (2021-2026) Table 145. Europe Diagnostic Nuclear Medicines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Europe Diagnostic Nuclear Medicines Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Diagnostic Nuclear Medicines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Diagnostic Nuclear Medicines Sales by Country (2021-2026) & (k units) Table 149. Asia-Pacific Diagnostic Nuclear Medicines Sales Market Share by Country (2021-2026) Table 150. Asia-Pacific Diagnostic Nuclear Medicines Sales Forecast by Country (2027-2032) & (k units) Table 151. Asia-Pacific Diagnostic Nuclear Medicines Sales Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Diagnostic Nuclear Medicines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Diagnostic Nuclear Medicines Market Size by Country (2021-2026) & (US$ Million) Table 154. Asia-Pacific Diagnostic Nuclear Medicines Market Share by Country (2021-2026) Table 155. Asia-Pacific Diagnostic Nuclear Medicines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Asia-Pacific Diagnostic Nuclear Medicines Market Share Forecast by Country (2027-2032) Table 157. Latin America Diagnostic Nuclear Medicines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 158. Latin America Diagnostic Nuclear Medicines Sales by Country (2021-2026) & (k units) Table 159. Latin America Diagnostic Nuclear Medicines Sales Market Share by Country (2021-2026) Table 160. Latin America Diagnostic Nuclear Medicines Sales Forecast by Country (2027-2032) & (k units) Table 161. Latin America Diagnostic Nuclear Medicines Sales Market Share Forecast by Country (2027-2032) Table 162. Latin America Diagnostic Nuclear Medicines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Latin America Diagnostic Nuclear Medicines Market Size by Country (2021-2026) & (US$ Million) Table 164. Latin America Diagnostic Nuclear Medicines Market Share by Country (2021-2026) Table 165. Latin America Diagnostic Nuclear Medicines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Latin America Diagnostic Nuclear Medicines Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Diagnostic Nuclear Medicines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Diagnostic Nuclear Medicines Sales by Country (2021-2026) & (k units) Table 169. Middle East and Africa Diagnostic Nuclear Medicines Sales Market Share by Country (2021-2026) Table 170. Middle East and Africa Diagnostic Nuclear Medicines Sales Forecast by Country (2027-2032) & (k units) Table 171. Middle East and Africa Diagnostic Nuclear Medicines Sales Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Diagnostic Nuclear Medicines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Diagnostic Nuclear Medicines Market Size by Country (2021-2026) & (US$ Million) Table 174. Middle East and Africa Diagnostic Nuclear Medicines Market Share by Country (2021-2026) Table 175. Middle East and Africa Diagnostic Nuclear Medicines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Middle East and Africa Diagnostic Nuclear Medicines Market Share Forecast by Country (2027-2032) Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Diagnostic Nuclear Medicines Distributors List Table 180. Diagnostic Nuclear Medicines Customers List Table 181. Research Programs/Design for This Report Table 182. Authors List of This Report Table 183. Secondary Sources Table 184. Primary Sources List of Figures Figure 1. Diagnostic Nuclear Medicines Image Figure 2. Global Diagnostic Nuclear Medicines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Diagnostic Nuclear Medicines Market Size (2021-2032) & (US$ Million) Figure 4. Global Diagnostic Nuclear Medicines Sales (2021-2032) & (k units) Figure 5. Tc-99m Image Figure 6. Global Tc-99m Sales YoY Growth (2021-2032) & (k units) Figure 7. F-18 Image Figure 8. Global F-18 Sales YoY Growth (2021-2032) & (k units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 11. Global Diagnostic Nuclear Medicines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Diagnostic Nuclear Medicines Market Share by Type 2025 VS 2032 Figure 13. North America Diagnostic Nuclear Medicines Sales Market Share in Volume by Type in 2025 Figure 14. North America Diagnostic Nuclear Medicines Sales Market Share in Value by Type in 2025 Figure 15. Europe Diagnostic Nuclear Medicines Sales Market Share in Volume by Type in 2025 Figure 16. Europe Diagnostic Nuclear Medicines Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Diagnostic Nuclear Medicines Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Diagnostic Nuclear Medicines Sales Market Share in Value by Type in 2025 Figure 19. Latin America Diagnostic Nuclear Medicines Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Diagnostic Nuclear Medicines Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Diagnostic Nuclear Medicines Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Diagnostic Nuclear Medicines Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Diagnostic Nuclear Medicines Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Oncology Image Figure 26. Global Oncology Sales YoY Growth (2021-2032) & (k units) Figure 27. Cardiology Image Figure 28. Global Cardiology Sales YoY Growth (2021-2032) & (k units) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 31. Global Diagnostic Nuclear Medicines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Diagnostic Nuclear Medicines Market Share by Application 2025 VS 2032 Figure 33. North America Diagnostic Nuclear Medicines Sales Market Share in Volume by Application in 2025 Figure 34. North America Diagnostic Nuclear Medicines Sales Market Share in Value by Application in 2025 Figure 35. Europe Diagnostic Nuclear Medicines Sales Market Share in Volume by Application in 2025 Figure 36. Europe Diagnostic Nuclear Medicines Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Diagnostic Nuclear Medicines Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Diagnostic Nuclear Medicines Sales Market Share in Value by Application in 2025 Figure 39. Latin America Diagnostic Nuclear Medicines Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Diagnostic Nuclear Medicines Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Diagnostic Nuclear Medicines Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Diagnostic Nuclear Medicines Sales Market Share in Value by Application in 2025 Figure 43. North America Diagnostic Nuclear Medicines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. North America Diagnostic Nuclear Medicines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Diagnostic Nuclear Medicines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Diagnostic Nuclear Medicines Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Diagnostic Nuclear Medicines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Europe Diagnostic Nuclear Medicines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Diagnostic Nuclear Medicines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Diagnostic Nuclear Medicines Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Diagnostic Nuclear Medicines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Asia-Pacific Diagnostic Nuclear Medicines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Diagnostic Nuclear Medicines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Diagnostic Nuclear Medicines Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Diagnostic Nuclear Medicines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Latin America Diagnostic Nuclear Medicines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Diagnostic Nuclear Medicines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Diagnostic Nuclear Medicines Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Diagnostic Nuclear Medicines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Middle East and Africa Diagnostic Nuclear Medicines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Diagnostic Nuclear Medicines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Diagnostic Nuclear Medicines Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Diagnostic Nuclear Medicines Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Diagnostic Nuclear Medicines Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Tc-99m
  • F-18
  • Other
Applications
  • Oncology
  • Cardiology
  • Other
Companies covered
  • Bracco Imaging
  • Cardinal Health
  • Curium Pharma
  • GE Healthcare
  • Jubilant Pharma
  • Lantheus
  • SIEMENS
  • Dongcheng
  • Eli Lilly
  • Novartis
  • China Isotope & Radiation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Diagnostic Nuclear Medicines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Diagnostic Nuclear Medicines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Diagnostic Nuclear Medicines Market by Type
  6. 1.3.1 Tc-99m
  7. 1.3.2 F-18
  8. 1.3.3 Other
  9. 1.4 Global Diagnostic Nuclear Medicines Market Size by Type
  10. 1.4.1 Global Diagnostic Nuclear Medicines Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Diagnostic Nuclear Medicines Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Diagnostic Nuclear Medicines Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Diagnostic Nuclear Medicines Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Diagnostic Nuclear Medicines Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Diagnostic Nuclear Medicines Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Diagnostic Nuclear Medicines Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Diagnostic Nuclear Medicines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Diagnostic Nuclear Medicines Industry Trends
  2. 2.2 Diagnostic Nuclear Medicines Industry Drivers
  3. 2.3 Diagnostic Nuclear Medicines Industry Opportunities and Challenges
  4. 2.4 Diagnostic Nuclear Medicines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Diagnostic Nuclear Medicines Revenue (2021-2026)
  2. 3.2 Global Top Players by Diagnostic Nuclear Medicines Sales (2021-2026)
  3. 3.3 Global Top Players by Diagnostic Nuclear Medicines Price (2021-2026)
  4. 3.4 Global Diagnostic Nuclear Medicines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Diagnostic Nuclear Medicines Major Company Production Sites & Headquarters
  6. 3.6 Global Diagnostic Nuclear Medicines Company, Product Type & Application
  7. 3.7 Global Diagnostic Nuclear Medicines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Diagnostic Nuclear Medicines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Diagnostic Nuclear Medicines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Diagnostic Nuclear Medicines Tier 1, Tier 2, and Tier 3
4 Diagnostic Nuclear Medicines Regional Status and Outlook
  1. 4.1 Global Diagnostic Nuclear Medicines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Diagnostic Nuclear Medicines Historic Market Size by Region
  3. 4.2.1 Global Diagnostic Nuclear Medicines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Diagnostic Nuclear Medicines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Diagnostic Nuclear Medicines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Diagnostic Nuclear Medicines Forecasted Market Size by Region
  7. 4.3.1 Global Diagnostic Nuclear Medicines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Diagnostic Nuclear Medicines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Diagnostic Nuclear Medicines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Diagnostic Nuclear Medicines by Application
  1. 5.1 Diagnostic Nuclear Medicines Market by Application
  2. 5.1.1 Oncology
  3. 5.1.2 Cardiology
  4. 5.1.3 Other
  5. 5.2 Global Diagnostic Nuclear Medicines Market Size by Application
  6. 5.2.1 Global Diagnostic Nuclear Medicines Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Diagnostic Nuclear Medicines Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Diagnostic Nuclear Medicines Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Diagnostic Nuclear Medicines Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Diagnostic Nuclear Medicines Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Diagnostic Nuclear Medicines Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Diagnostic Nuclear Medicines Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Diagnostic Nuclear Medicines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Bracco Imaging
  2. 6.1.1 Bracco Imaging Company Information
  3. 6.1.2 Bracco Imaging Business Overview
  4. 6.1.3 Bracco Imaging Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Bracco Imaging Diagnostic Nuclear Medicines Product Portfolio
  6. 6.1.5 Bracco Imaging Recent Developments
  7. 6.2 Cardinal Health
  8. 6.2.1 Cardinal Health Company Information
  9. 6.2.2 Cardinal Health Business Overview
  10. 6.2.3 Cardinal Health Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Cardinal Health Diagnostic Nuclear Medicines Product Portfolio
  12. 6.2.5 Cardinal Health Recent Developments
  13. 6.3 Curium Pharma
  14. 6.3.1 Curium Pharma Company Information
  15. 6.3.2 Curium Pharma Business Overview
  16. 6.3.3 Curium Pharma Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Curium Pharma Diagnostic Nuclear Medicines Product Portfolio
  18. 6.3.5 Curium Pharma Recent Developments
  19. 6.4 GE Healthcare
  20. 6.4.1 GE Healthcare Company Information
  21. 6.4.2 GE Healthcare Business Overview
  22. 6.4.3 GE Healthcare Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 GE Healthcare Diagnostic Nuclear Medicines Product Portfolio
  24. 6.4.5 GE Healthcare Recent Developments
  25. 6.5 Jubilant Pharma
  26. 6.5.1 Jubilant Pharma Company Information
  27. 6.5.2 Jubilant Pharma Business Overview
  28. 6.5.3 Jubilant Pharma Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Jubilant Pharma Diagnostic Nuclear Medicines Product Portfolio
  30. 6.5.5 Jubilant Pharma Recent Developments
  31. 6.6 Lantheus
  32. 6.6.1 Lantheus Company Information
  33. 6.6.2 Lantheus Business Overview
  34. 6.6.3 Lantheus Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Lantheus Diagnostic Nuclear Medicines Product Portfolio
  36. 6.6.5 Lantheus Recent Developments
  37. 6.7 SIEMENS
  38. 6.7.1 SIEMENS Company Information
  39. 6.7.2 SIEMENS Business Overview
  40. 6.7.3 SIEMENS Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 SIEMENS Diagnostic Nuclear Medicines Product Portfolio
  42. 6.7.5 SIEMENS Recent Developments
  43. 6.8 Dongcheng
  44. 6.8.1 Dongcheng Company Information
  45. 6.8.2 Dongcheng Business Overview
  46. 6.8.3 Dongcheng Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Dongcheng Diagnostic Nuclear Medicines Product Portfolio
  48. 6.8.5 Dongcheng Recent Developments
  49. 6.9 Eli Lilly
  50. 6.9.1 Eli Lilly Company Information
  51. 6.9.2 Eli Lilly Business Overview
  52. 6.9.3 Eli Lilly Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Eli Lilly Diagnostic Nuclear Medicines Product Portfolio
  54. 6.9.5 Eli Lilly Recent Developments
  55. 6.10 Novartis
  56. 6.10.1 Novartis Company Information
  57. 6.10.2 Novartis Business Overview
  58. 6.10.3 Novartis Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Novartis Diagnostic Nuclear Medicines Product Portfolio
  60. 6.10.5 Novartis Recent Developments
  61. 6.11 China Isotope & Radiation
  62. 6.11.1 China Isotope & Radiation Company Information
  63. 6.11.2 China Isotope & Radiation Business Overview
  64. 6.11.3 China Isotope & Radiation Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 China Isotope & Radiation Diagnostic Nuclear Medicines Product Portfolio
  66. 6.11.5 China Isotope & Radiation Recent Developments
7 North America by Country
  1. 7.1 North America Diagnostic Nuclear Medicines Sales by Country
  2. 7.1.1 North America Diagnostic Nuclear Medicines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Diagnostic Nuclear Medicines Sales by Country (2021-2026)
  4. 7.1.3 North America Diagnostic Nuclear Medicines Sales Forecast by Country (2027-2032)
  5. 7.2 North America Diagnostic Nuclear Medicines Market Size by Country
  6. 7.2.1 North America Diagnostic Nuclear Medicines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Diagnostic Nuclear Medicines Market Size by Country (2021-2026)
  8. 7.2.3 North America Diagnostic Nuclear Medicines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Diagnostic Nuclear Medicines Sales by Country
  2. 8.1.1 Europe Diagnostic Nuclear Medicines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Diagnostic Nuclear Medicines Sales by Country (2021-2026)
  4. 8.1.3 Europe Diagnostic Nuclear Medicines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Diagnostic Nuclear Medicines Market Size by Country
  6. 8.2.1 Europe Diagnostic Nuclear Medicines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Diagnostic Nuclear Medicines Market Size by Country (2021-2026)
  8. 8.2.3 Europe Diagnostic Nuclear Medicines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Diagnostic Nuclear Medicines Sales by Country
  2. 9.1.1 Asia-Pacific Diagnostic Nuclear Medicines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Diagnostic Nuclear Medicines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Diagnostic Nuclear Medicines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Diagnostic Nuclear Medicines Market Size by Country
  6. 9.2.1 Asia-Pacific Diagnostic Nuclear Medicines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Diagnostic Nuclear Medicines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Diagnostic Nuclear Medicines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Diagnostic Nuclear Medicines Sales by Country
  2. 10.1.1 South America Diagnostic Nuclear Medicines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Diagnostic Nuclear Medicines Sales by Country (2021-2026)
  4. 10.1.3 South America Diagnostic Nuclear Medicines Sales Forecast by Country (2027-2032)
  5. 10.2 South America Diagnostic Nuclear Medicines Market Size by Country
  6. 10.2.1 South America Diagnostic Nuclear Medicines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Diagnostic Nuclear Medicines Market Size by Country (2021-2026)
  8. 10.2.3 South America Diagnostic Nuclear Medicines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Diagnostic Nuclear Medicines Sales by Country
  2. 11.1.1 Middle East and Africa Diagnostic Nuclear Medicines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Diagnostic Nuclear Medicines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Diagnostic Nuclear Medicines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Diagnostic Nuclear Medicines Market Size by Country
  6. 11.2.1 Middle East and Africa Diagnostic Nuclear Medicines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Diagnostic Nuclear Medicines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Diagnostic Nuclear Medicines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Diagnostic Nuclear Medicines Value Chain Analysis
  2. 12.1.1 Diagnostic Nuclear Medicines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Diagnostic Nuclear Medicines Production Mode & Process
  7. 12.2 Diagnostic Nuclear Medicines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Diagnostic Nuclear Medicines Distributors
  10. 12.2.3 Diagnostic Nuclear Medicines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst